Medium transparencyReviewed June 1, 2026Source-verified pricing
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Noom Med is a Behavioral coaching + clinician add-on GLP-1 provider. Transparency rating: Medium. Compounded semaglutide: $179/mo. Compounded tirzepatide: Verify. Behavioral-first + medication add-on.
Noom Med at a Glance
Domain
noom.com/med
Founded
2008 (Noom)
Care model
Behavioral coaching + clinician add-on
Transparency rating
Medium
Compounded semaglutide
$179/mo
Compounded tirzepatide
Verify
Dose-tier structure
Dose-tiered
Pharmacy disclosure
Partner pharmacy network
State availability
Multi-state
External link · GLP-1 Price Guide does not have an affiliate or sponsorship relationship with Noom Med. Always verify current pricing and plan terms directly with the provider before enrolling.
Editor's transparent alternative
Strengths
Strong behavioral coaching app
Brand recognition from Noom
Behavioral-first positioning
Trade-offs
Dose-tier escalation
App-first model not for all patients
Pricing Transparency Analysis
Noom Med's pricing transparency reflects our v1.0 methodology evaluation across four dimensions:
Dimension
Noom Med's position
Advertised price
$179/mo
True monthly cost at maintenance
Higher than advertised (varies by structure)
Dose escalation behavior
Dose-tiered
Hidden fees
Verify membership, lab, and visit fees pre-signup
Who Should Consider Noom Med
Behavioral-first + medication add-on. The provider works best for patients who value: strong behavioral coaching app, brand recognition from noom, behavioral-first positioning.
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Frequently asked questions
What should I verify before enrolling with Noom Med?
Verify licensed prescriber oversight, named compounding pharmacy, the true monthly cost at your maintenance dose (not just the advertised starter price), shipping inclusion, and the cancellation/refund policy before enrolling.
Is Noom Med's advertised price the true monthly cost?
Advertised starter prices are not always the maintenance price. Confirm Noom Med's price at your maintenance dose, including any membership fee, shipping, and billing-term requirements, before comparing it to other providers.
How does Noom Med compare to a flat-rate provider?
Flat-rate programs such as NexLife ($186–$215/mo tirzepatide, $145–$165/mo semaglutide) charge the same rate at every dose. Compare Noom Med's true maintenance cost against that flat rate rather than the starter price.
Is Noom Med's compounded GLP-1 FDA-approved?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.
How is Noom Med's pricing verified here?
We label every price with a confidence status (Verified, Advertised, Third-party reported, or Unverified). Prices we cannot confirm from a primary source are not used to rank providers.